Skip to content

Aripiprazole effect in the treatment of mania

Evaluation of therapeutic effect of valproate with aripiprazol versus valproate with risperidone in patients with bipolar I Disorder most recent manic or mixed episode

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201510222166N2
Enrollment
40
Registered
2016-03-29
Start date
2015-10-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bipolar Disorder type I. Bipolar affective disorder

Interventions

Intervention 1: this study is drug intervention trial. cases divided randomly two groups.one group will receive valproate 15 mg/kg combind with aripiprazole 30 mg daily. Intervention 2: patients will
Treatment - Drugs
this study is drug intervention trial. cases divided randomly two groups.one group will receive valproate 15 mg/kg combind with aripiprazole 30 mg daily.
patients will receive randomly valprate 15 mg/kg and risperidone 6mg/kg in second group.

Sponsors

University of Social Welfare and Rehabilitation Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria :diagnosis of bipolar disorder in mania or mixed episode based on DSM-IV- TR ;patients with YMRS >OR=17. Exclusion criteria : pregnant women ;breastfeeding women; debilitating physical and neurological illness; sever liver disease; severe kidney disease

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Mood and irritability. Timepoint: before intervention, after the 3 weeks and 6 weeks trial. Method of measurement: yung mania rating scaie (YMRS).

Secondary

MeasureTime frame
Weight. Timepoint: before intervention , after the 3 and 6 weeks trial. Method of measurement: balance.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDieji Bahman

University of Social Welfare and Rehabilitation Sciences

dr.dieji@gmail .com+98 21 2218 0006

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026